Michael Tancer is an experienced executive in the biotechnology and pharmaceutical industry, currently serving as the Executive Director and Program Strategy Leader for Trodelvy Breast and GYN Cancer at Gilead Sciences since January 2023. Prior to this role, Tancer held key positions at Nektar Therapeutics, overseeing GU Marketing and Commercial Operations, and at Genentech, where significant contributions included leading the US launch of TECENTRIQ for breast cancer. Tancer's career began with a research assistant role at OHSU and has included extensive consulting experience at Campbell Alliance. Academic credentials include a Master’s in Biotechnology from Keck Graduate Institute and a Bachelor's in Biochemistry from Lewis & Clark College.
This person is not in any teams
This person is not in any offices